Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
- PMID: 33537329
- PMCID: PMC7848220
- DOI: 10.3389/fmed.2020.606824
Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
Keywords: COVID-19; SARS-CoV-2; myalgic encephalomyelitis/chronic fatigue syndrome; post-infectious fatigue syndrome; post-viral fatigue syndrome.
Conflict of interest statement
AK reports receiving personal fees from Serimmune Inc., Ono Pharma, and Deallus, and grants from the National Institutes of Health, for activities unrelated to the submitted work. LB is employed by the Bateman Horne Center which receives grants from the National Institutes of Health, and from BHC receives fees from Exagen, Inc., and Teva Pharmaceutical for activities unrelated to the submitted work.
References
-
- Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network. MMWR Morb Mortal Wkly Rep. (2020) 69:993–8. 10.15585/mmwr.mm6930e1 - DOI - PMC - PubMed
-
- Davis H, Assaf G, McCorkell L, Wei H, Low R, Re'em Y, et al. Symptomatic description of long COVID through 7 months in an international cohort. medRxiv. (2020). 10.1101/2020.12.24.20248802 - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous